What is the effect of Butyrate for APOE4 carriers?
Butyrate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.
Phoenix APOE4 Research · Reviewed by Kevin Tran, APOE4/4 carrier and founder · Data through 2026-08-23 · How to read this research
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsButyrate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Collecting evidence
Butyrate is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
Butyrate · 1 outcome shown.
HDL cholesterol: Increase 32.5 %
Cases: 1
Under review
One curated butyrate case raised HDL cholesterol 32.5% in 85 days; paired values were not published.
Butyrate
?Collecting evidenceOne curated butyrate case raised HDL cholesterol 32.5% in 85 days; paired values were not published.
Not explained by the science yetShort-chain fatty acid research on human metabolic outcomes is early and mostly preclinical; no established mechanism raises HDL from oral butyrate.
Collecting evidence
Butyrate is being tracked against HDL cholesterol, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
This result is under review: Not printed as of Release 001: the published +32.5% HDL case could not be re-confirmed against the member it was attributed to in the 23-Aug data pull. Held pending a correct member match, not printed as a finding.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.